CVS Caremark Corp (NYSE:CVS) Institutional Investors Q3 2017 Sentiment

The company was reinitiated on Wednesday, August 19 by Evercore. 1,775 were reported by Farmers Comml Bank.

Analysts are speculating a 26.55% move, based on the high target price ($100) for the shares that is set to reach in the next 12 months. The stock increased 0.76% or $0.5864 during the last trading session, reaching $78.0264. About 898,019 shares traded or 6.31% up from the average. It has underperformed by 10.29% the S&P500. The company has market cap of $477,513. The broad Health Care Plans industry has an average P/S ratio of 16.4, which is significantly worse than the sector's 6.83. The companyÂ's LoyaltyOne segment owns and operates the AIR MILES Reward Program and BrandLoyalty program that are coalition and short-term loyalty programs.

The Stock now has Analyst' mean Recommendation of 2.1 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. Therefore 53% are positive. Alliance Data Systems has $360 highest and $20 lowest target. The rating was maintained by Deutsche Bank with "Hold" on Wednesday, July 22. Five Below had 53 analyst reports since September 3, 2015 according to SRatingsIntel. Needham has "Buy" rating and $85.0 target.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. As per Tuesday, June 20, the company rating was downgraded by Wedbush. The company was maintained on Friday, October 13 by Piper Jaffray. The firm has "Buy" rating given on Thursday, May 12 by Jefferies. The stock has "Underperform" rating by Oppenheimer on Tuesday, April 11. The firm has "Overweight" rating given on Thursday, March 24 by JP Morgan. California Pub Employees Retirement reported 259,732 shares. Robert W. Baird restated a "hold" rating and set a $77.00 price target on shares of CVS Health in a report on Friday, October 27th. ADS's profit will be $264.09 million for 14.19 P/E if the $4.78 EPS becomes a reality. Howland Cap Management Lc reported 203,402 shares or 1.37% of all its holdings.

Investors sentiment increased to 1.03 in 2017 Q3. Its down 0.03, from 0.82 in 2017Q2. It dived, as 21 investors sold PHH Corporation shares while 28 reduced holdings. Numeric Invsts Ltd Llc accumulated 4,600 shares. Two Sigma Secs Ltd Limited Liability Company invested in 0.02% or 2,276 shares. First Allied Advisory Services owns 0.13% invested in CVS Health Corporation (NYSE:CVS) for 37,331 shares. Indexiq Advsrs Ltd holds 0.04% or 68,085 shares in its portfolio. Gsa Cap Prtn Ltd Liability Partnership stated it has 0.1% of its portfolio in MBIA Inc. Broderick Brian C owns 82,658 shares. Moreover, Rhenman Ptnrs Asset Mgmt Ab has 1.25% invested in CVS Health Corporation (NYSE:CVS). Avalon Advisors holds 868,777 shares or 2.06% of its portfolio. Financial Bank Of New York Mellon Corporation reported 238,515 shares. Endurance Wealth invested in 1.57% or 116,428 shares. Corporate insiders own 0.61% of the company's stock. Stifel holds 17,632 shares or 0% of its portfolio. Gillespie Robinson And Grimm stated it has 295,993 shares.

Honeywell International Inc. decreased its holdings in shares of CVS Health Corp (NYSE:CVS) by 33.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. Its down 0.04, from 0.92 in 2017Q2. MPS Loria Financial Planners LLC acquired a new position in shares of CVS Health in the 2nd quarter valued at $119,000. 88 funds opened positions while 466 raised stakes. The funds in our partner's database now own: 801.45 million shares, down from 803.96 million shares in 2017Q2. Fred Alger Management holds 48,189 shares. The institutional investor held 154,996 shares of the semiconductors company at the end of 2017Q3, valued at $13.92 million, up from 7,628 at the end of the previous reported quarter. Parametric Portfolio Assocs Llc owns 417,431 shares. Illinois-based Pekin Singer Strauss Asset Mgmt Il has invested 0.04% in CVS Health Corporation (NYSE:CVS). West Oak Capital Lc invested in 19,455 shares or 0.94% of the stock. De Burlo Gru Inc holds 3.35% in Microchip Technology Incorporated (NASDAQ:MCHP) or 168,333 shares. Credit Agricole S A invested 0.41% of its portfolio in CVS Health Corporation (NYSE:CVS). Finally, Needham & Company LLC raised CVS Health from a "hold" rating to a "buy" rating and raised their price target for the company from $69.02 to $79.00 in a report on Friday, November 10th. Therefore 72% are positive.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the company's stock in a transaction on Thursday, December 21st. The firm has "Market Perform" rating given on Thursday, August 11 by Keefe Bruyette & Woods. Integrated Wealth Management boosted its stake in shares of CVS Health Corporation by 3.8% in the third quarter. The firm has "Neutral" rating by Goldman Sachs given on Monday, September 26. Guggenheim reissued a "buy" rating and issued a $90.00 price objective (down from $115.00) on shares of CVS Health Corporation in a research note on Tuesday, November 8th. The rating was maintained by Robert W. Baird with "Hold" on Thursday, January 4. Cowen & Co maintained the stock with "Buy" rating in Tuesday, June 13 report.

Cadinha & Co Llc, which manages about $952.64M and $586.57M US Long portfolio, decreased its stake in Berkshire Hathaway Inc Cl B (BRKB) by 2,518 shares to 191,678 shares, valued at $35.14 million in 2017Q3, according to the filing. It also upped Barclays Bk Plc (DJP) stake by 61,449 shares and now owns 326,606 shares. Ishares Tr S&P Us Pfd Stk Inde (PFF) was raised too.

Since August 16, 2017, it had 0 insider buys, and 7 selling transactions for $58.32 million activity. Shares for $1.67 million were sold by Moriarty Thomas M on Monday, October 2. The insider Roberts Jonathan C sold 85,743 shares worth $7.13 million. The hedge fund run by Charles Clough held 370,700 shares of the prepackaged software company at the end of 2017Q3, valued at $27.61 million, up from 284,000 at the end of the previous reported quarter. 237,078 shares valued at $18.88 million were sold by Denton David M on Monday, September 11.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.49 by $0.01. CVS Health's revenue for the quarter was up 3.5% on a year-over-year basis. research analysts predict that CVS Health Corp will post 5.9 EPS for the current fiscal year.

Latest News